Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation

Sudden infant death syndrome (SIDS) represents a significant cause of post-neonatal mortality, yet its underlying mechanisms remain unclear. The triple-risk model of SIDS proposes that intrinsic vulnerability, exogenous triggers, and a critical developmental period are required for SIDS to occur. Al...

Full description

Bibliographic Details
Main Authors: Dénes Tóth, Gábor Simon, Dóra Reglődi
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/20/15063
_version_ 1797573682585927680
author Dénes Tóth
Gábor Simon
Dóra Reglődi
author_facet Dénes Tóth
Gábor Simon
Dóra Reglődi
author_sort Dénes Tóth
collection DOAJ
description Sudden infant death syndrome (SIDS) represents a significant cause of post-neonatal mortality, yet its underlying mechanisms remain unclear. The triple-risk model of SIDS proposes that intrinsic vulnerability, exogenous triggers, and a critical developmental period are required for SIDS to occur. Although case–control studies have identified potential risk factors, no in vivo model fully reflects the complexities observed in human studies. Pituitary adenylate cyclase-activating polypeptide (PACAP), a highly conserved neuropeptide with diverse physiological functions, including metabolic and thermal regulation, cardiovascular adaptation, breathing control, stress responses, sleep–wake regulation and immunohomeostasis, has been subject to early animal studies, which revealed that the absence of PACAP or its specific receptor (PAC1 receptor: PAC1R) correlates with increased neonatal mortality similar to the susceptible period for SIDS in humans. Recent human investigations have further implicated PACAP and PAC1R genes as plausible contributors to the pathomechanism of SIDS. This mini-review comprehensively synthesizes all PACAP-related research from the perspective of SIDS and proposes that PACAP deficiency might offer a promising avenue for studying SIDS.
first_indexed 2024-03-10T21:12:31Z
format Article
id doaj.art-2f250d4a4c5c4f7cbb05f16590808417
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T21:12:31Z
publishDate 2023-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-2f250d4a4c5c4f7cbb05f165908084172023-11-19T16:41:04ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-10-0124201506310.3390/ijms242015063Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for InvestigationDénes Tóth0Gábor Simon1Dóra Reglődi2Department of Forensic Medicine, University of Pécs Medical School, Szigeti út 12, H-7624 Pécs, HungaryDepartment of Forensic Medicine, University of Pécs Medical School, Szigeti út 12, H-7624 Pécs, HungaryDepartment of Anatomy, HUN-REG-PTE PACAP Research Team, Centre for Neuroscience, University of Pécs Medical School, Szigeti út 12, H-7624 Pécs, HungarySudden infant death syndrome (SIDS) represents a significant cause of post-neonatal mortality, yet its underlying mechanisms remain unclear. The triple-risk model of SIDS proposes that intrinsic vulnerability, exogenous triggers, and a critical developmental period are required for SIDS to occur. Although case–control studies have identified potential risk factors, no in vivo model fully reflects the complexities observed in human studies. Pituitary adenylate cyclase-activating polypeptide (PACAP), a highly conserved neuropeptide with diverse physiological functions, including metabolic and thermal regulation, cardiovascular adaptation, breathing control, stress responses, sleep–wake regulation and immunohomeostasis, has been subject to early animal studies, which revealed that the absence of PACAP or its specific receptor (PAC1 receptor: PAC1R) correlates with increased neonatal mortality similar to the susceptible period for SIDS in humans. Recent human investigations have further implicated PACAP and PAC1R genes as plausible contributors to the pathomechanism of SIDS. This mini-review comprehensively synthesizes all PACAP-related research from the perspective of SIDS and proposes that PACAP deficiency might offer a promising avenue for studying SIDS.https://www.mdpi.com/1422-0067/24/20/15063PACAPneuropeptidesudden infant death syndromeanimal model
spellingShingle Dénes Tóth
Gábor Simon
Dóra Reglődi
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation
International Journal of Molecular Sciences
PACAP
neuropeptide
sudden infant death syndrome
animal model
title Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation
title_full Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation
title_fullStr Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation
title_full_unstemmed Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation
title_short Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation
title_sort pituitary adenylate cyclase activating polypeptide pacap and sudden infant death syndrome a potential model for investigation
topic PACAP
neuropeptide
sudden infant death syndrome
animal model
url https://www.mdpi.com/1422-0067/24/20/15063
work_keys_str_mv AT denestoth pituitaryadenylatecyclaseactivatingpolypeptidepacapandsuddeninfantdeathsyndromeapotentialmodelforinvestigation
AT gaborsimon pituitaryadenylatecyclaseactivatingpolypeptidepacapandsuddeninfantdeathsyndromeapotentialmodelforinvestigation
AT dorareglodi pituitaryadenylatecyclaseactivatingpolypeptidepacapandsuddeninfantdeathsyndromeapotentialmodelforinvestigation